{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:33:43Z","timestamp":1770438823356,"version":"3.49.0"},"reference-count":27,"publisher":"Informa UK Limited","issue":"sup115","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1080\/030097401300232583","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:20:25Z","timestamp":1027682425000},"page":"1-13","source":"Crossref","is-referenced-by-count":29,"title":["The treatment of Sj\u00f6gren's syndrome patients with Pilocarpine-tablets"],"prefix":"10.1080","volume":"30","author":[{"given":"Frederick B.","family":"Vivino","sequence":"first","affiliation":[{"name":"Jefferson Sjogren\u2018s Syndrome Center, Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":"Sjogren H. Zur Kenntnis der keratoconjunctivitis sicca (kerat-itis filiforms beihypofunktion der tranendrusen). Acta Ophthal 1933; Suppl II: 1\u2013151."},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Talal N Moutsopoulos H Karsan S eds. SjOgren's Syndrome: Clinical and Immunologic Aspects. Heidelberg Germany: Springer-Verlag 1987.","DOI":"10.1007\/978-3-642-50118-0"},{"key":"e_1_2_1_4_1","first-page":"345","article-title":"Schiodt M","volume":"56","author":"Oxholm P","year":"1998","unstructured":"Oxholm P, Prause JU, Schiodt M. Rational drug therapy recommendations for the treatment of patients with Sjogren's syndrome. Drugs 1998;56:345\u201353.","journal-title":"Rational drug therapy recommendations for the treatment of patients with Sjogren's syndrome. Drugs"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.64.10.523"},{"key":"e_1_2_1_6_1","first-page":"255","article-title":"Shiozawa K","volume":"18","author":"Shiozawa S","year":"1998","unstructured":"Shiozawa S, Tanaka Y, Shiozawa K. Single- blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerosto-mia in patients with Sjogren's syndrome. J Interferon Cytokine Res 1998;18:255\u201362.","journal-title":"Single- blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerosto-mia in patients with Sjogren's syndrome. J Interferon Cytokine Res"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/107999099313497"},{"key":"e_1_2_1_8_1","first-page":"176","article-title":"On dry mouth, or suppression of the salivary and buccal secretions","volume":"20","author":"Hadden WB","year":"1888","unstructured":"Hadden WB. On dry mouth, or suppression of the salivary and buccal secretions. Trans Clin Soc Lond 1888;20:176\u20139.","journal-title":"Trans Clin Soc Lond"},{"key":"e_1_2_1_9_1","first-page":"1579","volume":"1","author":"Frost-Larsen K","year":"1978","unstructured":"Frost-Larsen K, Isager H, Manthorpe R. SjOgren's syndrome treated with bromhexine: a randomized clinical study. BMJ 1978;1:1579\u201381.","journal-title":"R. SjOgren's syndrome treated with bromhexine: a randomized clinical study. BMJ"},{"key":"e_1_2_1_10_1","first-page":"177","article-title":"Bromhexine treatment of Sjogren's syndrome","volume":"10","author":"Manthorpe R","year":"1981","unstructured":"Manthorpe R, Frost-Larsen K, Hoj L, et al. Bromhexine treatment of Sjogren's syndrome. Effect on lacrimal and saliv-ary secretion and on proteins in tear fluid and saliva. Scand J Rheumatology 1981;10:177\u201380.","journal-title":"Effect on lacrimal and saliv-ary secretion and on proteins in tear fluid and saliva. Scand J Rheumatology"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549010-00010"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308053290603"},{"key":"e_1_2_1_13_1","first-page":"1124","article-title":"Potter D","volume":"11","author":"LeVeque FG","year":"1993","unstructured":"LeVeque FG, Montgomery M, Potter D. et al. A multicenter, randomized, double-blind, placebo-controlled dose titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clinical Oncol 1993;11:1124\u201331.","journal-title":"et al. A multicenter, randomized, double-blind, placebo-controlled dose titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clinical Oncol"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.2.174"},{"key":"e_1_2_1_15_1","unstructured":"Papas A Charney M Goden H. et al. The effectiveness of oral pilocarpine-HC1 tablets for the treatment of dry mouth symptoms associated with SjOgren's syndrome - a dose-titration study. Arthritis Rheum. 1997;40 Suppl 9: S202."},{"key":"e_1_2_1_16_1","first-page":"979","article-title":"Yeatts RP","volume":"438","author":"Nelson JD","year":"1998","unstructured":"Nelson JD, Friedlaender MH, Yeatts RP. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with SjOgren's syndrome. The MGI Pharma SjOgren's Syndrome Study Group. Adv Exp Med Biol 1998;438:979\u201383.","journal-title":"Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with SjOgren's syndrome. The MGI Pharma SjOgren's Syndrome Study Group. Adv Exp Med Biol"},{"issue":"9","key":"e_1_2_1_17_1","first-page":"S353","article-title":"Long-term safety of pilocarpine tables following chronic administration to patients with SjOgren's syndrome for the relief of symptoms of dry mouth and dry eyes","volume":"41","author":"Vivino F","year":"1998","unstructured":"Vivino F, Leveque F, Khan Z, et al. Long-term safety of pilocarpine tables following chronic administration to patients with SjOgren's syndrome for the relief of symptoms of dry mouth and dry eyes. (Abstract), Arthritis Rheum 1998;41 Suppl 9:S353.","journal-title":"Abstract), Arthritis Rheum"},{"issue":"9","key":"e_1_2_1_18_1","first-page":"S139","article-title":"Sustained increases in salivary flow and safety findings following extended use of pilocarpine tablets for the treatment of dry mouth symptoms in patients with SjOgren's syndrome","volume":"42","author":"LeVeque F","year":"1999","unstructured":"LeVeque F, Khan Z, Salibury PL et al. Sustained increases in salivary flow and safety findings following extended use of pilocarpine tablets for the treatment of dry mouth symptoms in patients with SjOgren's syndrome. (Abstract), Arthritis Rheum 1999;42 Suppl 9:S139.","journal-title":"Abstract), Arthritis Rheum"},{"key":"e_1_2_1_19_1","unstructured":"Salagen tablets. In: Physicians Desk Reference 55th ed. Montvale NJ: Medical Economics Books 2000;1924\u20136."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00317-3"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00318-5"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345940730030901"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000261253"},{"key":"e_1_2_1_24_1","first-page":"350","article-title":"SjOgren's syndrome: Giving dry mouth and dry eyes the full treatment","volume":"17","author":"Vivino FB","year":"2000","unstructured":"Vivino FB, Orlin SE. SjOgren's syndrome: Giving dry mouth and dry eyes the full treatment. J Musculoskel Med 2000;17:350\u201367.","journal-title":"J Musculoskel Med"},{"key":"e_1_2_1_25_1","first-page":"705","article-title":"Candida albicans levels in patients with SjOgren's syndrome before and after long-term use of pilocarpine hydrochloride: A pilot study","volume":"29","author":"Rhodus NL","year":"1998","unstructured":"Rhodus NL, Liljemark W, Bloomquist BA, et al. Candida albicans levels in patients with SjOgren's syndrome before and after long-term use of pilocarpine hydrochloride: A pilot study. Quintessence Int 1998; 29:705\u201310.","journal-title":"Quintessence Int"},{"issue":"9","key":"e_1_2_1_26_1","first-page":"S408","article-title":"Scintigraphic predictors of response to treatment in SjOgren's syndrome","volume":"43","author":"Vivino FB","year":"2000","unstructured":"Vivino FB, Hermann GA: Scintigraphic predictors of response to treatment in SjOgren's syndrome. (Abstract), Arthritis Rheum 2000;43 Suppl 9:S408.","journal-title":"Abstract), Arthritis Rheum"},{"key":"e_1_2_1_27_1","first-page":"1260","article-title":"Variability of quantitative scintigraphic salivary indices in normals; causes and implications for xerostomic patients","volume":"39","author":"Hermann GA","year":"1998","unstructured":"Hermann GA, Vivino FB, Shnier D, et al. Variability of quantitative scintigraphic salivary indices in normals; causes and implications for xerostomic patients. J Nucl Med 1998;39:1260\u20133.","journal-title":"J Nucl Med"},{"key":"e_1_2_1_28_1","first-page":"637","volume":"53","author":"Vitali C","year":"1994","unstructured":"Vitali C, Moutsopoulus HM, Bombardieri S. et al. The European Community Study Group on diagnostic criteria for SjOgren's syndrome: sensitivity and specificity of tests for ocular and oral involvement in SjOgren's syndrome. Ann Rheum Dis 1994;53:637\u201347.","journal-title":"Bombardieri S. et al. The European Community Study Group on diagnostic criteria for SjOgren's syndrome: sensitivity and specificity of tests for ocular and oral involvement in SjOgren's syndrome. Ann Rheum Dis"}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/030097401300232583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:24:00Z","timestamp":1770387840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/030097401300232583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":27,"journal-issue":{"issue":"sup115","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1080\/030097401300232583"],"URL":"https:\/\/doi.org\/10.1080\/030097401300232583","relation":{},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}